Category: ConMed Corp.Syndicate content

Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014

August 21, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; ElectroCore seeks commercial partners for non-invasive headache tech; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Activist investor battles on over ConMed as shareholders vote approaches; Medtronic's Q1 earnings beat The Street on modest sales bump

Will Medtronic follow Walgreen and abandon inversion in Covidien deal?

August 15, 2014 by Brad Perriello

Activist investor battles on over ConMed as shareholders vote approaches

August 14, 2014 by Brad Perriello

Activist investor Voce Capital Management vies for ConMed shareholders' favor as the medical device company's annual meeting approaches.

Hedge funds battle over ConMed's board as shareholders meeting approaches

Ex-Stryker CFO Hartman takes over at ConMed

July 23, 2014 by Arezu Sarvestani

ConMed names former Stryker CFO Curt Hartman interim CEO and lowers its outlook for the rest of the year.

Former Styker CFO takes over at ConMED

Surgical device maker ConMed (NSDQ:CNMD) took a major hit on Wall Street today after announcing some turnover at the top and lowering its financial outlook for the rest of the year.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Embattled ConMed surges on reports of potential sale

April 16, 2014 by Arezu Sarvestani

Wall Street rallies for ConMed amid reports that the surgical devices maker is on the auction block after weeks of fighting a nasty 3-way proxy war.

ConMed surges on reports of potential sale

Surgical devices maker ConMed (NSDQ:CNMD) got a little Wall Street love after news sources reported today that the company may be up for sale.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

ConMed delays annual meeting amid proxy war

March 17, 2014 by Brad Perriello

ConMed delays its annual shareholders meeting amid a 3-way battle for control of the medical device company.

ConMed delays annual meeting amid proxy war

ConMed (NSDQ:CNMD) said last week that it's delaying its annual shareholders meeting amid a 3-way proxy war that turned nasty last month.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtech personnel moves for the week of Mar. 10, 2014

March 11, 2014 by MassDevice staff

Here's a look at some of the top personnel stories for medical device companies this week.

ConMed proxy war gets ugly

February 28, 2014 by Brad Perriello

ConMed proxy war gets ugly

The proxy war over control of the board at ConMed turned ugly this week after serious allegations surfaced against 1 of the medical device company's nominees for director.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp